Processa Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity Note: Schedule of Performance Stock Option Activity (Tables)

12 Months Ended

Dec. 31, 2013

	Number of Options	Weighted Average Exercise Price
Balance, December 31, 2011	1,400,000	$ 0.06
Granted	40,000	$ 2.00
Exercised	--	$ -
Cancelled	--	$ -
Balance, December 31, 2013 and December 31, 2012	1,440,000	$ 0.11
Exercisable, December 31, 2013 and December 31, 2012	40,000	$ 2.00